Preliminary study suggests Parkinson's drugs safe for the heart
The findings in non-ergot derived dopamine agonists need to be confirmed in larger studies
2014-12-04
(Press-News.org) Vienna, Austria - 04 December 2014: Non-ergot derived dopamine agonists used to treat Parkinson's disease may be safe for the heart, according to preliminary research presented at EuroEcho-Imaging 2014 by Dr Hilal Erken Pamukcu, cardiologist at Ankara Diskapi Education and Research Hospital in Turkey.
EuroEcho-Imaging is the annual meeting of the European Association of Cardiovascular Imaging (EACVI), a registered branch of the European Society of Cardiology (ESC), and is held 3-6 December in Vienna, Austria.
Dr Erken Pamukcu said: "Parkinson's disease is a neurological disorder that occurs in nearly 1% of the world's population over 60 years of age and in 4% of people over 80 years of age. Various drug treatments are available. Ergot derived dopamine agonists were often used in the past but today their usage is not preferred by most neurologists worldwide because they caused fibrotic heart valve disease and fibrosis in other tissues."
She continued: "Today, non-ergot derived dopamine agonists are widely used in daily clinical practice but recent studies have suggested that the non-ergot derived dopamine agonist pramipexole increases the risk of heart failure. In September 2012 the US Food and Drug Administration (FDA) informed the public about a possible increased risk of heart failure with pramipexole but the studies were inconclusive and the review is ongoing."1
The current study was designed to investigate whether the use of pramipexole and ropinirole, both non-ergot derived dopamine agonists, was associated with heart failure. Heart failure was deemed to occur if patients had asymptomatic myocardial dysfunction and deterioration of myocardial systolic function. These were assessed by examining left ventricular function using two-dimensional strain echocardiography.
The same measurements were made in patients taking levodopa, a drug commonly used in Parkinson's disease that does not have any adverse cardiac effects. Dr Erken Pamukcu explained: "We could not create a control group of Parkinson's disease patients who were not taking any drugs because most of these patients take one or more drugs. We therefore used patients taking only levodopa as a control group."
The study included 55 patients with Parkinson's disease, of which 24 were taking levodopa alone, 18 were using levodopa and pramipexole and 13 were using levodopa and ropinirole. The mean age of the study population was 63 years. There were no significant differences between groups in age, sex or presence of hypertension.
The researchers did not find any significant differences between groups in the global and segmental longitudinal strain length and strain rate values.
Dr Erken Pamukcu said: "Our measurements of left ventricular function produced similar values in all three treatment groups. We did not detect any evidence of asymptomatic myocardial dysfunction or deterioration of systolic function in patients taking pramipexole or ropinirole."
She continued: "As we did not show any statistically significant myocardial dysfunction in the groups taking pramipexole or ropinirole, our study suggests that these drugs do not cause heart damage. Our conclusion from this small, preliminary study is that non-ergot derived dopamine agonists are safe for the heart."
Dr Erken Pamukcu concluded: "We believe this is the first study to assess left ventricular function using two-dimensional strain echocardiography in Parkinson's disease patients taking non-ergot dopamine agonists. This may be a new approach to study the cardiac effects of these drugs. Larger studies are needed to confirm our results."
INFORMATION:
ELSE PRESS RELEASES FROM THIS DATE:
2014-12-04
Many patients with first-episode psychosis receive medications that do not comply with recommended guidelines for first-episode treatment, researchers have found. Current guidelines emphasize low doses of antipsychotic drugs and strategies for minimizing the side effects that might contribute to patients stopping their medication. A study finds that almost 40 percent of people with first-episode psychosis in community mental health clinics across the country might benefit from medication treatment changes.
Psychosis is a mental disorder in which thoughts and emotions ...
2014-12-04
It has been a long held belief that tumors arising from exposure to asbestos are caused by mutations in one cell, which then produces multiple clones. This hypothesis is challenged by new research published in the open access Journal of Translational Medicine, which suggests it is caused by mutations in multiple cells.
Malignant mesothelioma is a rare form of cancer that affects the mesothelium - the protective lining that covers the internal organs, such as the lungs, the heart and the abdominal cavity. It is estimated that malignant mesothelioma affects up to 3,200 ...
2014-12-04
Some previous studies have linked the diabetes medication pioglitazone to bladder cancer. However a new study − including more than one million people in six populations worldwide − has found no link between either pioglitazone or rosiglitazone (also known as Avandia) and bladder cancer. The new study is published in Diabetologia (the journal of the European Association for the Study of Diabetes), and is by Dr Samira Bell, Professor Helen Colhoun and Mr Danny Levin, University of Dundee, UK, and colleagues from the International Diabetes and Cancer Research ...
2014-12-04
Children born prematurely are at an increased risk of flu-related complications, despite not being identified as an "at risk" group in UK, USA, or WHO guidelines, and should be a priority group for the seasonal flu vaccination, new research published in The Lancet Respiratory Medicine suggests.
"Until now, guidelines highlighting groups at greater risk of developing complications from influenza, such as pneumonia, have been based on consensus opinion rather than on systematic assessment of the evidence"*, explains Dr Kay Wang from the University of Oxford in the UK. ...
2014-12-04
Researchers at the National Institutes of Health have found a duplication of a short stretch of the X chromosome in some people with a rare disorder that causes excessive childhood growth. They believe that a single gene within the region likely has a large influence on how much children grow. The research comes from a lab at NIH's Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which seeks to understand growth.
"Finding the gene responsible for childhood overgrowth would be very helpful, but the much wider question is what ...
2014-12-04
HOUSTON - (Dec. 3, 2014) - Rice University scientists have discovered an environmentally friendly carbon-capture method that could be equally adept at drawing carbon dioxide emissions from industrial flue gases and natural gas wells.
The Rice lab of chemist Andrew Barron revealed in a proof-of-concept study that amine-rich compounds are highly effective at capturing the greenhouse gas when combined with carbon-60 molecules.
The research is the subject of an open-access paper today in Nature's online journal Scientific Reports.
"We had two goals," Barron said. "One ...
2014-12-03
The longer surgery lasts the more prone patients appear to be to develop blood clots (venous thromboembolisms, VTE), according to a report published online by JAMA Surgery.
The association between longer surgical procedures and death, including VTE, is widely accepted but it has yet to be quantitatively addressed. More than 500,000 hospitalizations and 100,000 deaths are associated each year with VTEs. Examining the link between VTE and surgical time could allow for more informed medical and surgical decisions, according to the study background.
John Y.S. Kim, M.D., ...
2014-12-03
CHICAGO --- The longer the duration of surgery, the higher the risk of a life-threatening blood clot, according to the first large-scale, quantitative national study of the risk across all surgical procedures.
The Northwestern Medicine study was published Dec. 3 in JAMA Surgery, the Journal of the American Medical Association.
The finding will help guide surgical decision-making by enabling surgeons and patients to better understand the potential risk of procedures. These findings may also spur surgeons to take more aggressive preventative measures such as giving ...
2014-12-03
WASHINGTON, Dec. 3, 2014--The ability to detect when to harvest "climacteric" fruits -- such as apples, bananas, pears and tomatoes -- at the precise moment to ensure "peak edibleness" in terms of both taste and texture may soon be within reach for farmers, thanks to the work of a team of researchers from Saint Joseph University in Lebanon and the Université de Bretagne Occidentale de Brest in France.
As the team reports in a paper published in The Optical Society's (OSA) journal Applied Optics, they recently demonstrated a laser biospeckle technique capable of detecting ...
2014-12-03
New Orleans, LA - A multi-institutional study reports an effective treatment approach to inhibit and keep latent viruses like herpes simplex from reactivating and causing disease. The work, whose lead author is the late James Hill, PhD, LSU Health New Orleans Professor and Director of Pharmacology and Infectious Disease at the LSU Eye Center, is published in the December 3, 2014, issue of Science Translational Medicine.
The research team, led by Thomas M. Kristie, PhD, Chief of the Molecular Genetics Section in the National Institute of Allergy and Infectious Diseases' ...
LAST 30 PRESS RELEASES:
[Press-News.org] Preliminary study suggests Parkinson's drugs safe for the heart
The findings in non-ergot derived dopamine agonists need to be confirmed in larger studies
